about
Chemopreventive Effects of Dietary Eicosapentaenoic Acid Supplementation in Experimental Myeloid Leukemia.New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation.A clinical observation of Chinese chronic myelogenous leukemia patients after discontinuation of tyrosine kinase inhibitors.Management of the new patient with CML in chronic phase.Discontinuation of tyrosine kinase therapy in CML.ST1926, an orally active synthetic retinoid, induces apoptosis in chronic myeloid leukemia cells and prolongs survival in a murine model.Use of the Word “Cure” in the Oncology Literature
P2860
Q36132830-AB77861E-5448-4902-843D-C841F6707B93Q37344050-54F0B47B-4603-4016-B68E-EEF4B680563EQ37629012-B2B2D1A1-2195-42FC-88DC-3D3931DFC1B6Q38079151-59765B0B-9FA2-47E4-938E-EB3A20B93218Q38392692-B5E71967-48F4-4317-B1B0-908B20171683Q38923368-ED2AB376-CEB4-4F1E-91B5-9BE6FEFF07B5Q57765732-DC754F10-49D3-4CA2-B51F-88F4681C0D12
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Curing chronic myeloid leukemia.
@en
Curing chronic myeloid leukemia.
@nl
type
label
Curing chronic myeloid leukemia.
@en
Curing chronic myeloid leukemia.
@nl
prefLabel
Curing chronic myeloid leukemia.
@en
Curing chronic myeloid leukemia.
@nl
P2093
P2860
P1476
Curing chronic myeloid leukemia.
@en
P2093
François-Xavier Mahon
Joelle Guilhot
Philippe Rousselot
P2860
P2888
P304
P356
10.1007/S11899-012-0117-2
P577
2012-06-01T00:00:00Z